These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8650107)

  • 21. Influence of Newcastle disease virus on the severity of Pasteurella anatipestifer infection in turkeys.
    Charles SD; Nagaraja KV; Halvorson DA; Barnes DM
    Res Vet Sci; 1993 Sep; 55(2):209-14. PubMed ID: 8235089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INVESTIGATIONS ON THE VARIABILITY OF THE PATHOGENICITY OF NEWCASTLE DISEASE VIRUS (NDV). IV. INFLUENCE OF BACTERIAL INFECTION (PASTEURELLA MULTOCIDA) AND PARASITIC INVASION (ASCARIDIA GALLI).
    ZEBROWSKI L; MAJEWSKA H; BYCZYNSKI Z
    Acta Microbiol Pol (1952); 1964; 13():205-10. PubMed ID: 14211341
    [No Abstract]   [Full Text] [Related]  

  • 23. Possible genetic variation in resistance of turkeys to erysipelas and fowl cholera.
    Saif YM; Nestor KE; Dearth RN; Renner PA
    Avian Dis; 1984; 28(3):770-3. PubMed ID: 6487197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Pasteurella multocida mutants of low virulence. I. Development and pathogenicity.
    Hofacre CL; Glisson JR; Kleven SH; Brown J; Rowland GN
    Avian Dis; 1989; 33(2):270-4. PubMed ID: 2751559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and characteristics of Pasteurella multocida in commercial turkeys.
    Aye PP; Angrick EJ; Morishita TY; Harr BS
    Avian Dis; 2001; 45(1):182-90. PubMed ID: 11332480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of complement sensitivity with virulence of Pasteurella multocida isolated from turkeys.
    Snipes KP; Hirsh DC
    Avian Dis; 1986; 30(3):500-4. PubMed ID: 3767810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Turkey macrophage and heterophil bactericidal activity against Pasteurella multocida.
    Harmon BG; Glisson JR; Nunnally JC
    Avian Dis; 1992; 36(4):986-91. PubMed ID: 1485882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of protection against avian cholera by vaccination with recombinant P6-like protein from Pasteurella multocida.
    Kasten RW; Wakenell PS; Ahmad S; Yilma TD; Hirsh DC
    Avian Dis; 1997; 41(4):972-6. PubMed ID: 9454935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct and correlated responses to long-term selection for increased body weight and egg production in turkeys.
    Nestor KE; Noble DO; Zhu NJ; Moritsu Y
    Poult Sci; 1996 Oct; 75(10):1180-91. PubMed ID: 8893292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pasteurella multocida: antibody-mediated resistance to virulent challenge exposure in vaccinated turkeys.
    Nathanson RM; Hofstad MS; Jeska EL
    Am J Vet Res; 1980 Aug; 41(8):1285-7. PubMed ID: 7447124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of live avirulent PM-1 and CU fowl cholera vaccines in turkeys.
    Hopkins BA; Olson LD
    Avian Dis; 1997; 41(2):317-25. PubMed ID: 9201394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of enzyme-linked immunosorbent assay with dot immunobinding assay for detection of antibodies against Pasteurella multocida in turkeys.
    Choi KH; Maheswaran SK; Molitor TW
    Avian Dis; 1990; 34(3):539-47. PubMed ID: 2241679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of hypovitaminosis A on the pathogenesis of Pasteurella multocida in turkeys.
    Aye PP; Morishita TY; Saif YM; Jonas M
    Avian Dis; 2000; 44(4):818-26. PubMed ID: 11195636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-protection against fowl cholera disease with the use of recombinant Pasteurella multocida FHAB2 peptides vaccine.
    Tatum FM; Tabatabai LB; Briggs RE
    Avian Dis; 2012 Sep; 56(3):589-91. PubMed ID: 23050479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sialic acid uptake is necessary for virulence of Pasteurella multocida in turkeys.
    Tatum FM; Tabatabai LB; Briggs RE
    Microb Pathog; 2009 Jun; 46(6):337-44. PubMed ID: 19366625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
    Heckert RA; Riva J; Cook S; McMillen J; Schwartz RD
    Avian Dis; 1996; 40(4):770-7. PubMed ID: 8980804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of turkeys with cell-free culture filtrate of Pasteurella multocida: effects of dilution, iron chelation, and heterologous challenge.
    Ficken MD; Barnes HJ; Avakian AP; Carver DK
    Avian Dis; 1992; 36(4):975-85. PubMed ID: 1485881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fowl cholera bacterins: host-specific cross-immunity induced in turkeys with Pasteurella multocida propagated in embryonating turkey eggs.
    Heddleston KL; Rebers PA
    Avian Dis; 1974; 18(2):231-9. PubMed ID: 4133381
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunologic response of turkeys to an avirulent Pasteurella multocida vaccine in the drinking water. 2. Duration of immunity.
    Bierer BW; Derieux WT
    Poult Sci; 1972 Jul; 51(4):1402-8. PubMed ID: 4630561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.